157 related articles for article (PubMed ID: 31901200)
1. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
[TBL] [Abstract][Full Text] [Related]
2. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
4. Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury.
Omotoso BA; Turgut F; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
Nephron; 2017; 136(2):95-102. PubMed ID: 28249270
[TBL] [Abstract][Full Text] [Related]
5. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
[TBL] [Abstract][Full Text] [Related]
6. Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods.
Shiao CC; Wu PC; Wu VC; Lin JH; Pan HC; Yang YF; Lai TS; Huang TM; Wu CH; Yang WS; Wu CJ; Kao CC; Sun CY; Huang CT; Lee KH; Lin CY; Chen TC; Hu FC; Liou HH; Lu KC; Chien KL; Wang JJ; Kan WC; Kuo FC; Lin HY; Chen CM; You ZH; Tsai JP; Weng CJ; Chen HY; Chang CF; Hsu WD; Wu MS; Huang CC; Wu KD;
Nephrology (Carlton); 2016 Sep; 21(9):758-64. PubMed ID: 27546777
[TBL] [Abstract][Full Text] [Related]
7. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
[TBL] [Abstract][Full Text] [Related]
8. Dialysis requirement, long-term major adverse cardiovascular events (MACE) and all-cause mortality in hospital acquired acute kidney injury (AKI): a propensity-matched cohort study.
Omotoso BA; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
J Nephrol; 2016 Dec; 29(6):847-855. PubMed ID: 27307250
[TBL] [Abstract][Full Text] [Related]
9. Postdischarge long-term cardiovascular outcomes of intensive care unit survivors who developed dialysis-requiring acute kidney injury after cardiac surgery.
Lee S; Park S; Kang MW; Yoo HW; Han K; Kim Y; Lee JP; Joo KW; Lim CS; Kim YS; Kim H; Kim DK
J Crit Care; 2019 Apr; 50():92-98. PubMed ID: 30502689
[TBL] [Abstract][Full Text] [Related]
10. Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.
Peng YC; Lin CL; Yeh HZ; Chang CS; Wu YL; Kao CH
Medicine (Baltimore); 2016 Apr; 95(15):e3363. PubMed ID: 27082596
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of upper gastrointestinal hemorrhage after advanced AKI.
Wu PC; Wu CJ; Lin CJ; Wu VC;
Clin J Am Soc Nephrol; 2015 Mar; 10(3):353-62. PubMed ID: 25527706
[TBL] [Abstract][Full Text] [Related]
12. Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study.
Gammelager H; Christiansen CF; Johansen MB; Tønnesen E; Jespersen B; Sørensen HT
Crit Care; 2013 Jul; 17(4):R145. PubMed ID: 23876346
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.
Chen SW; Lu YA; Lee CC; Chou AH; Wu VC; Chang SW; Fan PC; Tian YC; Tsai FC; Chang CH
PLoS One; 2019; 14(3):e0212352. PubMed ID: 30865662
[TBL] [Abstract][Full Text] [Related]
14. Nephrologist Follow-Up Care of Patients With Acute Kidney Disease Improves Outcomes: Taiwan Experience.
Wu VC; Chueh JS; Chen L; Huang TM; Lai TS; Wang CY; Chen YM; Chu TS; Chawla LS
Value Health; 2020 Sep; 23(9):1225-1234. PubMed ID: 32940241
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of active tuberculosis following acute kidney injury: a nationwide, population-based study.
Wu VC; Wang CY; Shiao CC; Chang CH; Huang HY; Huang TM; Lai CF; Lin MC; Ko WJ; Wu KD; Yu CJ; Shu CC; Lee CH; Wang JY; ;
PLoS One; 2013; 8(7):e69556. PubMed ID: 23936044
[TBL] [Abstract][Full Text] [Related]
17. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
20. Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors.
Chen CY; Wu VC; Lin CJ; Lin CS; Pan CF; Chen HH; Lin YF; Huang TM; Chen L; Wu CJ;
Mayo Clin Proc; 2018 Dec; 93(12):1760-1774. PubMed ID: 30343892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
